Literature DB >> 25208498

GC-EI-MS analysis of fatty acid composition in brain and serum of twitcher mouse.

Assunta Zanfini1, Elena Dreassi, Anna Berardi, Paola Piomboni, Elvira Costantino-Ceccarini, Alice Luddi.   

Abstract

Globoid cell leukodystrophy or Krabbe disease is an inherited autosomal recessive disorder caused by mutations in the galactosylceramidase gene. The objective of the study was to present information about the fatty acid (FA) composition of the brain and serum of twitcher mice, a mouse model of Krabbe disease, compared to wild type, in order to identify biomarker of disease progression. We defined the FA profiles by identifying the main components present in serum and brain using GC-EI-MS analysis. The FA percentage composition was measured and data were analyzed considering the disease and the mouse age as experimental factors. Significant correlations were established, both in brain and in serum, in the fatty acid percentage composition of twitcher compared to wild type mice. The most abundant saturated fatty acid in brain was the palmitic acid (C16:0) with mean values significantly increased in twitcher mouse (p = 0.0142); moreover, three monounsaturated, three polyunsaturated (PUFA) and a plasmalogen were significantly correlated to disease. In the serum highly significant differences were observed between the two groups for three polyunsaturated fatty acids. In fact, the docosahexaenoic acid (C22:6n3c) content was significantly increased (p = 0.0116), while the C20 PUFA (C20:3n6c and C20:5n3c) were significantly decreased in twitcher serum samples. Our study shows a specific FA profile that may help to define a possible pattern that could distinguish between twitcher and wild type; these data are likely to provide insight in the identification of new biomarkers to monitor the disease progression and thereby permit the critical analysis of therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25208498     DOI: 10.1007/s11745-014-3945-0

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  42 in total

Review 1.  Lipid changes in Niemann-Pick disease type C brain: personal experience and review of the literature.

Authors:  M T Vanier
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Prostaglandin D2-mediated microglia/astrocyte interaction enhances astrogliosis and demyelination in twitcher.

Authors:  Ikuko Mohri; Masako Taniike; Hidetoshi Taniguchi; Takahisa Kanekiyo; Kosuke Aritake; Takashi Inui; Noriko Fukumoto; Naomi Eguchi; Atsuko Kushi; Hitoshi Sasai; Yoshihide Kanaoka; Keiichi Ozono; Shuh Narumiya; Kinuko Suzuki; Yoshihiro Urade
Journal:  J Neurosci       Date:  2006-04-19       Impact factor: 6.167

Review 3.  Metabolomics: available results, current research projects in breast cancer, and future applications.

Authors:  Wederson Marcos Claudino; Alessandro Quattrone; Laura Biganzoli; Marta Pestrin; Ivano Bertini; Angelo Di Leo
Journal:  J Clin Oncol       Date:  2007-05-14       Impact factor: 44.544

4.  Extraction of lipids from human whole serum and lipoproteins and from rat liver tissue with methylene chloride-methanol: a comparison with extraction with chloroform-methanol.

Authors:  L A Carlson
Journal:  Clin Chim Acta       Date:  1985-06-30       Impact factor: 3.786

5.  PREPARATION OF FATTY ACID METHYL ESTERS AND DIMETHYLACETALS FROM LIPIDS WITH BORON FLUORIDE--METHANOL.

Authors:  W R MORRISON; L M SMITH
Journal:  J Lipid Res       Date:  1964-10       Impact factor: 5.922

6.  Myelin in the developing human cerebrum.

Authors:  M Martinez
Journal:  Brain Res       Date:  1986-02-05       Impact factor: 3.252

7.  Creating a fatty acid methyl ester database for lipid profiling in a single drop of human blood using high resolution capillary gas chromatography and mass spectrometry.

Authors:  Beatriz Bicalho; Frank David; Klaus Rumplel; Erick Kindt; Pat Sandra
Journal:  J Chromatogr A       Date:  2008-09-25       Impact factor: 4.759

Review 8.  Fatty acids, lipid metabolism and Alzheimer pathology.

Authors:  Carlijn R Hooijmans; Amanda J Kiliaan
Journal:  Eur J Pharmacol       Date:  2008-02-29       Impact factor: 4.432

9.  Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks.

Authors:  O Fiehn
Journal:  Comp Funct Genomics       Date:  2001

10.  Transduction of cultured oligodendrocytes from normal and twitcher mice by a retroviral vector containing human galactocerebrosidase (GALC) cDNA.

Authors:  E Costantino-Ceccarini; A Luddi; M Volterrani; M Strazza; M A Rafi; D A Wenger
Journal:  Neurochem Res       Date:  1999-02       Impact factor: 3.996

View more
  3 in total

1.  Metabolic profiling reveals biochemical pathways and potential biomarkers associated with the pathogenesis of Krabbe disease.

Authors:  Nadav I Weinstock; Lawrence Wrabetz; M Laura Feltri; Daesung Shin
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

2.  Quantitative Microproteomics Based Characterization of the Central and Peripheral Nervous System of a Mouse Model of Krabbe Disease.

Authors:  Davide Pellegrini; Ambra Del Grosso; Lucia Angella; Nadia Giordano; Marialaura Dilillo; Ilaria Tonazzini; Matteo Caleo; Marco Cecchini; Liam A McDonnell
Journal:  Mol Cell Proteomics       Date:  2019-03-29       Impact factor: 5.911

3.  Sulfatides Primarily Exist in the Substantia Nigra Region of Mouse Brain Tissue.

Authors:  Kab-Tae Park; Jong Cheol Shon; Ji-Eun Kim; Gyu Hwan Park; Hyun Jin Choi; Kwang-Hyeon Liu
Journal:  Lipids       Date:  2017-01-11       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.